TITLE

ALLHAT: What has it taught us so far?

AUTHOR(S)
Leenen, Frans H. H.
PUB. DATE
September 2004
SOURCE
CMAJ: Canadian Medical Association Journal;9/28/2004, Vol. 171 Issue 7, p719
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Provides information on the ALLHAT study which compared the incidence of fatal and nonfatal myocardial infarction among patients assigned to take a calcium-channel blocker (CCB), an angiotensin-converting-enzyme (ACE) inhibitor or a thiazide diuretic for their hypertension. Reason for the decision of many physicians in the 1990s to stop prescribing diuretics for older patients with hypertension in favor of ACE inhibitors and CCB; Development of congestive heart failure in the patients; Adverse events associated with the treatments.
ACCESSION #
14423503

 

Related Articles

  • ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS & HYDROCHLOROTHIAZIDE. GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2010, p48 

    The article presents information on angiotensin-converting enzyme (ACE) inhibitors and hydrochlorothiazide, a drug developed to treat high blood pressure and congestive heart failure, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible...

  • ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS. GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2011, p44 

    The article presents information on angiotensin-converting enzyme (ACE) inhibitors, a drug developed to treat hypertension, congestive heart failure and acute myocardial infarction, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible...

  • ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS & HYDROCHLOROTHIAZIDE. GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2011, p46 

    The article presents information on angiotensin-converting enzyme (ACE) inhibitors and hydrochlorothiazide, drugs developed to treat hypertension and congestive heart failure and to reduce fluid retention, including its dosage, usage, adverse reactions, side effects, precautions when...

  • Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 3: Angiotensin-converting-enzyme inhibitors. Wright, James M. // CMAJ: Canadian Medical Association Journal;8/08/2000, Vol. 163 Issue 3, p293 

    Abstract Elevated blood pressure is associated with an increased risk of cardiovascular illness and death. Efforts to reduce that risk have led to recommendations for a wide array of nondrug and drug therapies. Choosing the optimal first-line drug for hypertensive patients should address a...

  • Association Between Cardiovascular Outcomes and Antihypertensive Drug Treatment in Older Women. Wassertheil-Smoller, Sylvia; Psaty, Bruce; Greenland, Philip; Oberman, Albert; Kotchen, Theodore; Mouton, Charles; Black, Henry; Aragaki, Aaron; Trevisan, Maurizio // JAMA: Journal of the American Medical Association;12/15/2004, Vol. 292 Issue 23, p2849 

    Context Diuretic-based therapy is at least as effective as newer classes of agents for hypertension. However, many patients with hypertension require treatment with more than 1 drug class to achieve blood pressure control. The relative benefits or risks of 2-drug-class combinations are not well...

  • MY ABCD ALTERNATIVE. Kaul, Gulshan // Pulse;3/23/2006, Vol. 66 Issue 12, p47 

    The article suggests an alternative model for hypertension management in Great Britain. For patients over 55 years old or black patients of any age, first choice of treatment is calcium channel blocker, with thiazide diuretic as alternative. The second treatment of choice is ACE inhibitor. For...

  • DIURETICS, POTASSIUM-SPARING.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2007, p332 

    The article presents information on diuretics, potassium-sparing, an antihypertensive, antihypokalemic agent used for the treatment of congestive heart failure and hypertension. The dosage and usage information is provided. The possible adverse reactions or side effects of the drug, warnings,...

  • DIURETICS, POTASSIUM-SPARING & HYDROCHLOROTHIAZIDE.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2007, p334 

    The article presents information on diuretics, potassium-sparing and hydrochlorothiazide, an antihypertensive agent used for the treatment of congestive heart failure and hypertension. The dosage and usage information is provided. The possible adverse reactions or side effects of the drug,...

  • DIURETICS, POTASSIUM-SPARING & HYDROCHLOROTHIAZIDE. GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2011, p336 

    The article presents information on diuretics, potassium-sparing and hydrochlorothiazide, drugs for the treatment of hypertension and congestive heart failure, including their dosage, side effects, precautions when administering, and possible interaction with other drugs.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics